SciSparc’s Ordinary Shares to Commence Trading on Nasdaq Capital Market Today

TEL AVIV, Israel, Dec. 22, 2021 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced that its ordinary shares…

About the Author

has written 41672 stories on this site.

Copyright © 2010 Business and Corporate News.